Respiratory Failure Clinic, General Hospital of Thessaloniki "G. Papanikolaou", Aristotle University of Thessaloniki, Thessaloniki, Greece.
Department of Respiratory Medicine, General Hospital "G. Papanikolaou", Thessaloniki, Greece.
Pulmonology. 2024 Mar-Apr;30(2):104-112. doi: 10.1016/j.pulmoe.2022.03.012. Epub 2022 May 11.
Left-heart dysfunction and pulmonary vasculopathy are increasingly recognized as contributing factors of exercise capacity limitation in interstitial fibrosing lung disease (IFLD). Moreover, the clinical significance of exercise pulmonary hypertension (ePH) in pulmonary and cardiac diseases has been documented, representing a risk factor for decreased exercise capacity and survival, progression to resting pulmonary hypertension (PH) and overall clinical worsening. We conducted a prospective study aiming at: (a) assessing the prevalence of PH and ePH in a cohort of 40 functionally limited patients with IFLD, (b) determining the post-capillary (postC) or pre-capillary (preC) etiology of either PH or ePH in this cohort, and (c) examining the correlations between invasively and non-invasively measured exercise variables among hemodynamic groups.
40 IFLD patients underwent cardiopulmonary evaluation, including: clinical examination, lung function tests, 6-minute walking test, heart ultrasonography, cardiopulmonary exercise test and, finally, right heart catheterization (RHC). Resting hemodynamic evaluation was followed by the exercise protocol proposed by Herve et al, using a bedside cycle ergometer in the supine position. Abnormal elevation of mean pulmonary artery pressure (mPAP) above 30mmHg during exercise, with respect to abnormal elevation of cardiac output (CO) below 10 L/min (mPAP-CO ratio ⩾3 mmHg·min·L) was used to define ePH (Herve et al, 2015). Secondary hemodynamic evaluation involved detection of abnormal pulmonary arterial wedge pressure (PAWP) increase at peak exercise in relation to CO. Specifically, ΔPAWP/ΔCO >2 mmHg/L per minute determined an abnormal PAWP elevation (Bentley et al, 2020).
Among the 40-patient cohort, 25% presented postC PH, 37.5% preC PH, 27.5% ePH, with the remaining 10% recording normal hemodynamics. PAWP evaluation during exercise revealed a postC etiology in 4 out of the 11 patients presenting ePH, and a postC etiology in 6 out of the 15 patients presenting resting preC PH. Mean values of non-invasive variables did not display statistically significant differences among hemodynamic groups, except for: diffusing capacity for carbon monoxide (DLCO), carbon monoxide transfer coefficient (KCO) and the ratio of functional vital capacity to DLCO (FVC%/DLCO%), which were lower in both ePH and PH groups (p < 0.05). Resting values of CO, cardiac index (CI), stroke volume (SV) and pulmonary vascular compliance (PVC) were significantly impaired in ePH, preC-PH and postC-PH groups when compared to the normal group.
Both PH and ePH were highly prevalent within the IFLD patient group, suggesting that RHC should be offered more frequently in functionally limited patients. Diffusion capacity markers must thus guide decision making, in parallel to clinical evaluation. ePH was associated to lower resting CO and PVC, in a similar way to resting PH, indicating the relevance of cardiopulmonary function to exercise limitation. Finally, the use of the ΔPAWP/ΔCO>2 criterion further uncovered PH of postcapillary etiology, highlighting the complexity of hemodynamics in IFLD.
gov ID: NCT03706820.
左心功能障碍和肺血管病越来越被认为是间质性纤维化肺疾病(IFLD)运动能力受限的因素。此外,运动性肺动脉高压(ePH)在肺部和心脏疾病中的临床意义已经得到证实,它是运动能力下降和生存、进展为静息性肺动脉高压(PH)和整体临床恶化的危险因素。我们进行了一项前瞻性研究,旨在:(a)评估 40 名功能受限的 IFLD 患者中 PH 和 ePH 的患病率,(b)确定该队列中 PH 或 ePH 的毛细血管后(postC)或毛细血管前(preC)病因,以及(c)检查血流动力学组之间通过侵入性和非侵入性测量的运动变量之间的相关性。
40 名 IFLD 患者接受了心肺评估,包括:临床检查、肺功能测试、6 分钟步行测试、心脏超声、心肺运动测试,最后是右心导管检查(RHC)。在休息时进行血流动力学评估后,按照 Hervé 等人提出的运动方案进行,使用仰卧位床边自行车测力计。运动时平均肺动脉压(mPAP)异常升高超过 30mmHg,同时心输出量(CO)异常升高低于 10L/min(mPAP-CO 比值 ⩾3mmHg·min·L),用于定义 ePH(Hervé 等人,2015 年)。次要血流动力学评估包括检测峰值运动时肺动脉楔压(PAWP)异常升高与 CO 的关系。具体而言,ΔPAWP/ΔCO ⁇ 2mmHg/L 每分钟决定了异常的 PAWP 升高(Bentley 等人,2020 年)。
在 40 名患者队列中,25%的患者出现毛细血管后 PH,37.5%的患者出现毛细血管前 PH,27.5%的患者出现 ePH,其余 10%的患者记录正常血流动力学。在 11 名出现 ePH 的患者中,有 4 名在运动时 PAWP 评估显示为毛细血管后病因,在 15 名出现静息性毛细血管前 PH 的患者中,有 6 名显示为毛细血管后病因。血流动力学组之间的非侵入性变量平均值没有统计学上的显著差异,除了:一氧化碳弥散量(DLCO)、一氧化碳传递系数(KCO)和功能肺活量与 DLCO 的比值(FVC%/DLCO%),在 ePH 和 PH 组中均较低(p ⁇ 0.05)。在 ePH、preC-PH 和 postC-PH 组中,CO、心指数(CI)、每搏输出量(SV)和肺血管顺应性(PVC)的静息值均显著受损,与正常组相比。
PH 和 ePH 在 IFLD 患者群体中均高度流行,这表明在功能受限的患者中应更频繁地提供 RHC。因此,扩散能力标志物必须与临床评估并行指导决策。ePH 与较低的静息 CO 和 PVC 相关,与静息 PH 相似,这表明心肺功能与运动受限有关。最后,使用 ΔPAWP/ΔCO ⁇ 2 标准进一步揭示了毛细血管后病因的 PH,突出了 IFLD 血流动力学的复杂性。
gov ID:NCT03706820。